Science and Enterprise

Tag: equity

  • Clinical, Drug Discovery Biotech Companies Announce Merger

    Senesco Technologies, a clinical stage biotechnology company  in Bridgewater, New Jersey says it has a non-binding merger agreement with Fabrus Inc. in La Jolla, California, a drug-discovery biotechnology firm. Financial details of the merger were not disclosed, although the companies plan to reveal the terms when they finalize the agreement in early 2014. Senesco develops…

  • Bayer Acquires Cancer Drug Developer Algeta for $2.9B

    The global pharmaceutical company Bayer Group based in Germany is buying the specialty drug company Algeta ASA in Oslo, Norway for NOK 17.6 billion (USD 2.9 billion). Algeta, developer of a radium-based drug to treat prostate cancer, says its board of directors approved the sale, subject to confirmation by shareholders. Bayer and Algeta collaborated on…

  • Genome Editing Start-Up Secures $43M in First Round Funds

    The Cambridge, Massachusetts start-up Editas Medicine, developing therapies based on new research in genome editing, gained $43 million in its first financing round. The funding was led by venture companies Flagship Ventures, Polaris Partners, and Third Rock Ventures, with participation from Partners Innovation Fund, the venture funding arm of  Massachusetts General Hospital and Brigham and…

  • Inflammation Drug Biotech Lands $32.4M in Venture Funding

    Catabasis Pharmaceuticals Inc., a clinical-stage biotechnology company in Cambridge, Massachusetts, completed its second venture funding round, securing $32.4 million. The round was led by new investor Lightstone Ventures, with participation by the company’s current investors: SV Life Sciences, Clarus Ventures, MedImmune Ventures, and Advanced Technology Ventures. Catabasis Pharmaceuticals develops medications to treat cardiovascular, metabolic and inflammatory…

  • 3-D Printer Maker Lands $19 Million in First Venture Funds

    Formlabs, a developer of three-dimensional printing technology in Somerville, Massachusetts, secured $19 million in its first venture funding. The financing round was led by venture capital company DFJ, with Pitango Venture Capital, Innovation Endeavors, and returning angel investors. Formlabs is a spin-off from MIT’s Media Lab, founded in 2011 by three engineers and designers. The…

  • St. Jude Medical Acquires Leadless Pacemaker Developer

    St. Jude Medical, a medical device company in St. Paul, Minnesota, is acquiring Nanostim Inc., a developer of self-contained leadless heart pacemakers in Sunnyvale, California. Shareholders in the privately owned Nanostim can receive up to $188.5 million in upfront cash and milestone payments as a result of the purchase. St. Jude Medical has a relationship…

  • Biotech Company to Go Public in $86 Million IPO

    GlycoMimetics Inc., a biotechnology company in Gaithersburg, Maryland, filed its registration with the U.S. Securities and Exchange Commission for a proposed initial public offering (IPO) of common stock. Fortune Magazine’s Term Sheet page reports the company aims to raise $86.25 million through the IPO, and trade on the Nasdaq exchange under ticker symbol GLYC. GlycoMimetics…

  • Investment Fund to Finance Global Health Technologies

    A consortium of private sector, foundation, and government partners formed the Global Health Investment Fund, to finance higher-risk, late-stage development of vaccines and other public health innovations in low-income countries. The fund is led by the bank JPMorgan Chase and the Bill & Melinda Gates Foundation, with contributions from Grand Challenges Canada (funded by the…

  • Biotech Financing Up, Licensing Down in First Half of 2013

    The biotechnology industry experienced healthy growth in venture financing and valuations in the first half of 2013, but licensing deals — a prime source of biotech revenue — were flat during the period, pointing to limits on the industry’s growth potential. This accounting of biotech industry financial activity is described in a report from Evaluate…

  • Lab-On-Chip Diagnostics Company Lands $2.1M Angel Financing

    ChipCare Corp., a spin-off company from University of Toronto in Canada developing hand-held diagnostics devices to replace fixed expensive lab equipment, secured $2.05 million in early stage angel financing. The deal combines investments from university, private-sector, and Canadian government sources, according to an announcement by Grand Challenges Canada, a government-financed organization supporting medical innovations in…